{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:51:44Z","timestamp":1790373104888,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.cyto.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T19:09:52Z","timestamp":1416683392000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The dual nature of interleukin-10 in pemphigus vulgaris"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4628-303X","authenticated-orcid":false,"given":"Michael Jeffrey","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph T.","family":"Ellebrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee S.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.11.002_b0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2014.11.002_b0010","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","article-title":"Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice","volume":"66","author":"Sellon","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2014.11.002_b0015","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","article-title":"Inflammatory bowel disease and mutations affecting the interleukin-10 receptor","volume":"361","author":"Glocker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0020","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(10)61008-2","article-title":"Infant colitis\u2013it\u2019s in the genes","volume":"376","author":"Glocker","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2014.11.002_b0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0035","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1073\/pnas.0914500107","article-title":"IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection","volume":"107","author":"Brooks","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.002_b0040","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1084\/jem.180.1.223","article-title":"B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation","volume":"180","author":"Murphy","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaci.2007.04.004","article-title":"IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1","volume":"120","author":"Taylor","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1074-7613(00)80404-5","article-title":"Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling","volume":"7","author":"Koppelman","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.11.002_b0060","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/eji.1830250940","article-title":"Interleukin-10 differentially regulates B7\u20131 (CD80) and B7\u20132 (CD86) expression on human peripheral blood dendritic cells","volume":"25","author":"Buelens","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0065","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.154.6.2668","article-title":"Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7\u20131 (CD80) and B7\u20132 (CD86) expression","volume":"154","author":"Mitra","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0075","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2567.1999.00828.x","article-title":"Interleukin-10-induced CD8 cell proliferation","volume":"98","author":"Rowbottom","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2014.11.002_b0080","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1128\/JVI.74.10.4729-4737.2000","article-title":"Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes","volume":"74","author":"Santin","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2014.11.002_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002371-199408000-00003","article-title":"Stimulation of cytolytic activity by interleukin-10","volume":"16","author":"Schwarz","year":"1994","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0090","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood.V85.12.3577.bloodjournal85123577","article-title":"The functional characterization of interleukin-10 receptor expression on human natural killer cells","volume":"85","author":"Carson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2014.11.002_b0095","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.002_b0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1172\/JCI116977","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0105","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.160.7.3188","article-title":"Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells","volume":"160","author":"Groux","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0110","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.154.9.4341","article-title":"The role of IL-10 in human B cell activation, proliferation, and differentiation","volume":"154","author":"Itoh","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(06)70577-1","article-title":"The two faces of interleukin 10 in human infectious diseases","volume":"6","author":"Mege","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cyto.2014.11.002_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0125","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0130","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.002_b0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0140","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4049\/jimmunol.149.1.92","article-title":"Identification and induction of keratinocyte-derived IL-10","volume":"149","author":"Enk","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0145","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.4049\/jimmunol.149.12.3865","article-title":"Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10","volume":"149","author":"Rivas","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0150","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.20041789","article-title":"T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation","volume":"200","author":"Roers","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0155","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ni1504","article-title":"Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10","volume":"8","author":"Maynard","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.11.002_b0165","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2014.11.002_b0170","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.11.002_b0180","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.4049\/jimmunol.0900185","article-title":"Nonredundant roles for B cell-derived IL-10 in immune counter-regulation","volume":"183","author":"Madan","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0185","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coi.2014.02.009","article-title":"From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets","volume":"28","author":"Dang","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12176","article-title":"B10 cell regulation of health and disease","volume":"259","author":"Candando","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2014.11.002_b0195","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.1102500","article-title":"Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo","volume":"188","author":"Maseda","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0200","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ceb.2004.07.006","article-title":"Desmosomes and disease: pemphigus and bullous impetigo","volume":"16","author":"Payne","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cyto.2014.11.002_b0205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI115968","article-title":"Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic","volume":"90","author":"Amagai","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/clin.1997.4408","article-title":"Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence","volume":"85","author":"Mascaro","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.cyto.2014.11.002_b0220","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1172\/JCI24185","article-title":"Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display","volume":"115","author":"Payne","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5167","article-title":"Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients","author":"Cho","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2014.11.002_b0230","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.181.2.1526","article-title":"Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris","volume":"181","author":"Takahashi","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0235","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.164.1.522","article-title":"Immune modulation in pemphigus vulgaris: role of CD28 and IL-10","volume":"164","author":"Toto","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0240","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1093\/emboj\/20.14.3760","article-title":"Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology","volume":"20","author":"Kontoyiannis","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2014.11.002_b0245","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1073\/pnas.0602973103","article-title":"P38MAPK inhibition prevents disease in pemphigus vulgaris mice","volume":"103","author":"Berkowitz","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.002_b0250","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1074\/jbc.M109.087999","article-title":"P38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis","volume":"285","author":"Jolly","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.11.002_b0255","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1074\/jbc.M110.172874","article-title":"P38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris","volume":"286","author":"Mao","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.11.002_b0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/jid.2013.224","article-title":"MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris","volume":"134","author":"Mao","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0265","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00403-004-0528-6","article-title":"Cytokine polymorphisms in patients with pemphigus","volume":"296","author":"Eberhard","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cyto.2014.11.002_b0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1468-3083.2009.03260.x","article-title":"TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population","volume":"24","author":"Javor","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cyto.2014.11.002_b0275","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1006\/cyto.1999.0642","article-title":"Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid","volume":"12","author":"Bhol","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.11.002_b0280","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of T(H)1\/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000063895","article-title":"Cytokine pattern in blister fluid and sera of patients with pemphigus","volume":"205","author":"Baroni","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2014.11.002_b0290","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cyto.2007.12.007","article-title":"Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy","volume":"41","author":"Keskin","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.11.002_b0295","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00915155","article-title":"Subclass distribution of human IgG autoantibodies in pemphigus","volume":"8","author":"Jones","year":"1988","journal-title":"J Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2014.11.002_b0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000246938","article-title":"Correlation of subclasses of IgG with disease activity in pemphigus vulgaris","volume":"189","author":"Bhol","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2014.11.002_b0305","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1073\/pnas.92.11.5239","article-title":"Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity","volume":"92","author":"Bhol","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.11.002_b0310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2133.2000.03659.x","article-title":"The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives","volume":"143","author":"Kricheli","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cyto.2014.11.002_b0320","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0325","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.183.3.937","article-title":"Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes","volume":"183","author":"Malisan","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0330","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.174.8.4718","article-title":"T regulatory-1 cells induce IgG4 production by B cells: role of IL-10","volume":"174","author":"Satoguina","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0335","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0340","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cyto.2014.11.002_b0345","first-page":"415","article-title":"Inhibition of complement activation by IgG4 antibodies","volume":"64","author":"van der Zee","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0350","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1084\/jem.168.1.127","article-title":"Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q","volume":"168","author":"Bindon","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0355","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaci.2005.06.004","article-title":"Allergen-specific immunotherapy with recombinant grass pollen allergens","volume":"116","author":"Jutel","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0360","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2012.02.026","article-title":"Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections","volume":"129","author":"Senti","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0365","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","article-title":"Serologic aspects of IgG4 antibodies. 1. Prolonged immunization results in an IgG4-restricted response","volume":"130","author":"Aalberse","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0370","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2014.11.002_b0375","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.4049\/jimmunol.1003224","article-title":"CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game","volume":"187","author":"Long","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0380","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.170.1.635","article-title":"Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles","volume":"170","author":"Veldman","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0385","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.172.6.3883","article-title":"T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0390","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0395","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.micro.58.030603.123836","article-title":"Cell-mediated immunity and the outcome of hepatitis C virus infection","volume":"58","author":"Shoukry","year":"2004","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.cyto.2014.11.002_b0400","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tim.2007.02.006","article-title":"IL-10, T cell exhaustion and viral persistence","volume":"15","author":"Blackburn","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.cyto.2014.11.002_b0405","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0410","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0415","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI117031","article-title":"Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus","volume":"93","author":"Clerici","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2014.11.002_b0420","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2005.06.003","article-title":"Blocking of interleukin-10 receptor\u2013a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus","volume":"117","author":"Rigopoulou","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0425","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cmi.2012.60","article-title":"Regulatory B Cells in autoimmune diseases","volume":"10","author":"Yang","year":"2013","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0435","article-title":"Impaired function of CD19 CD24 CD38 regulatory B cells in pemphigus patients","author":"Zhu","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0440","doi-asserted-by":"crossref","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0445","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar2076","article-title":"Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"8","author":"Vallerskog","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2014.11.002_b0450","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.4049\/jimmunol.0902551","article-title":"Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells","volume":"184","author":"Yang","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0455","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mus.23951","article-title":"Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis","volume":"49","author":"Sun","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cyto.2014.11.002_b0460","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.1780371114","article-title":"In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren\u2019s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity","volume":"37","author":"Llorente","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.002_b0465","first-page":"565","article-title":"Cytokine production, serum levels and disease activity in systemic lupus erythematosus","volume":"18","author":"Grondal","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0470","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/096120339500400510","article-title":"Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity","volume":"4","author":"Houssiau","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.cyto.2014.11.002_b0475","first-page":"283","article-title":"Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus","volume":"16","author":"Park","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0480","first-page":"2314","article-title":"Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus","volume":"24","author":"Lazarus","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0485","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.166.6.3915","article-title":"Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus","volume":"166","author":"Gibson","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0490","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.179.1.305","article-title":"Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB\/W F1 mice","volume":"179","author":"Ishida","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0495","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0500","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF01541225","article-title":"Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis","volume":"16","author":"al-Janadi","year":"1996","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cyto.2014.11.002_b0505","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2","article-title":"Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus","volume":"43","author":"Llorente","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.002_b0510","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 levels in patients with rheumatoid arthritis","volume":"38","author":"Cush","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2014.11.002_b0515","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.11.002_b0520","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1365-2567.1997.00244.x","article-title":"Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis","volume":"91","author":"Kawakami","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2014.11.002_b0525","first-page":"648","article-title":"Interleukin 10 treatment of patients with rheumatoid arthritis enhances Fc gamma receptor expression on monocytes and responsiveness to immune complex stimulation","volume":"30","author":"van Roon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2014.11.002_b0530","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2814","article-title":"Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis","volume":"11","author":"Schwager","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2014.11.002_b0535","unstructured":"Combination Therapy of F8-IL10 and Methotrexate in Rheumatoid Arthritis Patients. www clinicaltrials gov; 2014. NCT02076659."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:08:15Z","timestamp":1689685695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614005845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1043466614005845"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.11.002","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual nature of interleukin-10 in pemphigus vulgaris","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}